“Rheumatoid Factor Positivity Rather Than Anti-CCP Positivity, a Lower Disability and a Lower Number of Anti-TNFα Agents Failed Are Associated With Response to Rituximab in Rheumatoid Arthritis”. 2009. Reumatismo 61 (3): 182-86. https://doi.org/10.4081/reumatismo.2009.182.